|
SLC25A30 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.839920E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.396700E-03 |
| Normal-vs-Stage2 |
6.834600E-01 |
| Normal-vs-Stage3 |
1.104340E-03 |
| Normal-vs-Stage4 |
5.434000E-04 |
| Stage1-vs-Stage2 |
9.540100E-02 |
| Stage1-vs-Stage3 |
3.173400E-01 |
| Stage1-vs-Stage4 |
1.391620E-01 |
| Stage2-vs-Stage3 |
4.368500E-02 |
| Stage2-vs-Stage4 |
2.102400E-02 |
| Stage3-vs-Stage4 |
5.182800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.95139999999272E-05 |
| Normal-vs-AfricanAmerican |
1.348010E-01 |
| Normal-vs-Asian |
7.475600E-02 |
| Caucasian-vs-AfricanAmerican |
3.190000E-01 |
| Caucasian-vs-Asian |
6.438200E-01 |
| AfricanAmerican-vs-Asian |
6.649200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.8862000000538E-06 |
| Normal-vs-Female |
2.206400E-02 |
| Male-vs-Female |
3.796500E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.256100E-03 |
| Normal-vs-Age(41-60Yrs) |
7.173200E-04 |
| Normal-vs-Age(61-80Yrs) |
3.035400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.161900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.930200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.040400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.137240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.167620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.364210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.659500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.412780E-01 |
| Classical-VS-Follicular |
6.49269999999369E-05 |
| Classical-VS-Other |
4.985400E-01 |
| Classical-VS-Normal |
2.29210000000091E-05 |
| Tall-VS-Follicular |
1.62025999999038E-05 |
| Tall-VS-Other |
8.617200E-01 |
| Tall-VS-Normal |
2.35489999999006E-05 |
| Follicular-VS-Other |
6.199800E-03 |
| Follicular-VS-Normal |
1.433960E-01 |
| Other-VS-Normal |
1.162110E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.210970E-01 |
| Normal-vs-N1 |
5.20700000006258E-07 |
| N0-vs-N1 |
2.161800E-04 |
|
|
